Yichao Medical Launches National Key R&D Project: Development of an Intelligent Dual-Engine Dynamic Hybrid Energy Surgical System

Upholding the commitment to driving clinical transformation through original Chinese innovations, Shanghai Yichao Medical Device Co., Ltd. is continuously leading the development of minimally invasive surgical equipment with its pain point-oriented product innovation and R&D. Recently, the National Key R&D Program’s Special Project on Diagnostic and Therapeutic Equipment and Biomedical Materials—“Development of an Intelligent Dual-Engine Dynamic Hybrid Energy Surgical System”—was officially launched, with Professor Li Bin from Shanghai Sixth People’s Hospital serving as the project leader and Shanghai Yichao Medical Device Co., Ltd. as the lead organization.

“The joint project application by Shanghai Yichao Medical Device Co., Ltd. and Shanghai Sixth People’s Hospital represents a model example of industry-academia-research-clinical integration between technology-based small and medium-sized enterprises (SMEs) and medical institutions in Shanghai. This initiative not only stimulates collaborative translation capabilities among industry, academia, research, and clinical sectors but also significantly enhances the translation and application of scientific and technological achievements in medical devices.”

Deputy Director, Biotechnology and Medicine Division, Shanghai Municipal Science and Technology Commission, Dong Lianyan

“The Development of an Intelligent Dual-Engine Dynamic Hybrid Energy Surgical System” project has been implemented at the Zhangjiang Medical Device Industrial Base, not only promoting deep integration between R&D manufacturers and medical institutions, but also playing a significant demonstrative and leading role in advancing the transformation of medical device achievements within the park.

Deputy General Manager, Shanghai Zhangjiang Medical Device Industry Development Co., Ltd.Yang Yuanfang

“The Intelligent Dual-Engine Dynamic Hybrid Energy Surgical System is an internationally advanced, domestically original product under development by Yichao Medical. It addresses the scientific challenge of dynamically blending and modulating two energy outputs based on tissue characteristics, not only filling a domestic gap but also leading the next generation of energy-based surgical devices.”

Project Leader——Professor Li Bin, Shanghai Sixth People's Hospital

The “homologous control + real-time feedback + dynamic adjustment” of ultrasonic and electrical energy, along with anti-interference and insulation design during acoustic energy conduction and emission, represent this product’s wholly original innovations and serve as its unique “hallmark.” Compared with similar products, this device achieves international leading standards across numerous R&D technologies—from the energy generator and energy emitter to the integrated hybrid-energy handpiece—thereby filling domestic gaps in China.

“Leveraging the differential responses of human tissues to varying energy levels, we have developed a novel technology featuring dynamic hybrid output of ultrasonic and electrical energy. This system enables dual-energy mixed output, provides real-time feedback on tissue characteristics based on cutting conditions, and dynamically adjusts the dual-energy delivery. This innovation marks a technological leap in surgical procedures, transitioning from single-energy output to hybrid-energy output.”

Lead Organization of the Project——Feng Qingyu, Founder and General Manager of Yichao Medical

Enhancing clinical value to achieve social and economic benefits is a fundamental requirement for innovative products. Achieving “straight-track overtaking” in the medical device industry through original Chinese innovation is also the goal and mission of Yichao Medical.

In terms of clinical efficacy, this product enhances hemostatic performance while increasing cutting speed, ensuring that thermal injury is not increased, thereby achieving comprehensive improvements in cutting, hemostasis, and thermal injury control. Regarding clinical application, the product’s integrated design covers nearly all clinical cutting and hemostasis scenarios, significantly reducing the consumption of main units and disposables. In terms of surgical safety, as the product integrates the functions of multiple therapeutic devices, it eliminates the need for frequent switching of disposables during surgery, improving procedural flow, minimizing risks associated with device changes, and enhancing overall surgical safety. Furthermore, its full-scenario coverage enables more effective management of various emergencies, thereby improving rescue capabilities.

“Yichao Medical’s Preliminary Exploration of a Clinical Pain Point-Driven Product Innovation System: Focusing on Identifying Clinical Pain Points from Physicians’ Patents and Leveraging Corporate Product Micro-Navigation to Facilitate the Development of Innovative Technical Solutions. By Fully Harnessing Patent Data to Drive Technological and Product Breakthroughs, the Company Aims to Create Truly Original Products with Demonstrable Clinical Value.”

Director of the Yichao Medical Innovation Center, Wang Yi

Yichao Medical has collected nearly 170,000 valid and pending physician patents through systematic retrieval. These patents are indexed across multiple dimensions—including regulatory classification, clinical pain points, application departments, disease types, and lesion locations—to analyze technological development trends and the distribution of innovative R&D in various subfields of medical devices. This approach facilitates the identification of clinical pain points, emerging innovation hotspots, and technological trends within relevant fields. Based on the analytical results of physician patents, a joint innovation working group comprising clinical engineers, R&D engineers, and clinicians was established to curate innovative products and leverage patent micro-navigation to drive proactive development of innovative technical solutions.

Cai Kui, President of the Application Evaluation Branch of the China Association of Medical Equipment and Deputy Head of the Expert Group for the Special Guidelines on Diagnostic and Therapeutic Equipment and Biomaterials under the Ministry of Science and Technology; Sun Jingsheng, Vice President of the Application Evaluation Branch of the China Association of Medical Equipment and Chairman of Shuimu Medical; Ma Xibo, Researcher at the Institute of Automation, Chinese Academy of Sciences; Tao Chao, Professor in the Department of Physics at Nanjing University; and Cao Shaoping, Senior Engineer at Shanghai Children’s Medical Center, participated in the on-site review. Li Hongyi, Director of the Department of Cardiology at Beijing Hospital; Li Zhou, Researcher at the Beijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences; Zuo Xinian, Professor at Beijing Normal University; Li Yang, Professor and Deputy Dean at Beihang University; and Gao Mingyuan, Executive Dean of the School of Radiation Medicine and Protection at Soochow University, participated in the online review.

The experts fully affirmed the research value of this project and provided pertinent recommendations on how to solidly advance its implementation. They expressed the hope that the project’s undertaking entity would conduct in-depth research into landmark achievements, product reliability verification, and confirmation of clinical application scenarios; diligently carry out project management, clinical surveys, and metric evaluation; and, while meeting the technical assessment indicators specified in the project guidelines, achieve higher product performance metrics. Ultimately, the goal is to realize industrialization of the project, thereby achieving genuine Chinese originality and enabling China’s medical device industry to “overtake on a straight track.”